ITGAM and neoplasm: The number of proliferating cells and blood vessels and the percentage of CD11b+Gr-1+ MDSCs were also markedly decreased in tumor tissues from WP1066 treated wild-type mice compared with wild-type mice with no treatment (Figures 5(c)–5(e)).